These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 26999091)
1. Searching for Multi-Targeting Neurotherapeutics against Alzheimer's: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif. Pisani L; Farina R; Soto-Otero R; Denora N; Mangiatordi GF; Nicolotti O; Mendez-Alvarez E; Altomare CD; Catto M; Carotti A Molecules; 2016 Mar; 21(3):362. PubMed ID: 26999091 [TBL] [Abstract][Full Text] [Related]
2. Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents. Pisani L; Farina R; Catto M; Iacobazzi RM; Nicolotti O; Cellamare S; Mangiatordi GF; Denora N; Soto-Otero R; Siragusa L; Altomare CD; Carotti A J Med Chem; 2016 Jul; 59(14):6791-806. PubMed ID: 27347731 [TBL] [Abstract][Full Text] [Related]
3. Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase. Kumar B; Kumar V; Prashar V; Saini S; Dwivedi AR; Bajaj B; Mehta D; Parkash J; Kumar V Eur J Med Chem; 2019 Sep; 177():221-234. PubMed ID: 31151057 [TBL] [Abstract][Full Text] [Related]
4. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease. Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051 [TBL] [Abstract][Full Text] [Related]
5. Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease. Xu YX; Wang H; Li XK; Dong SN; Liu WW; Gong Q; Wang TD; Tang Y; Zhu J; Li J; Zhang HY; Mao F Eur J Med Chem; 2018 Jan; 143():33-47. PubMed ID: 29172081 [TBL] [Abstract][Full Text] [Related]
6. Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer's disease: Design, synthesis and biological evaluation. He Q; Liu J; Lan JS; Ding J; Sun Y; Fang Y; Jiang N; Yang Z; Sun L; Jin Y; Xie SS Bioorg Chem; 2018 Dec; 81():512-528. PubMed ID: 30245233 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site. Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902 [TBL] [Abstract][Full Text] [Related]
8. Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors. Reis J; Cagide F; Valencia ME; Teixeira J; Bagetta D; Pérez C; Uriarte E; Oliveira PJ; Ortuso F; Alcaro S; Rodríguez-Franco MI; Borges F Eur J Med Chem; 2018 Oct; 158():781-800. PubMed ID: 30245401 [TBL] [Abstract][Full Text] [Related]
9. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents. Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361 [TBL] [Abstract][Full Text] [Related]
10. Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease. Sterling J; Herzig Y; Goren T; Finkelstein N; Lerner D; Goldenberg W; Miskolczi I; Molnar S; Rantal F; Tamas T; Toth G; Zagyva A; Zekany A; Finberg J; Lavian G; Gross A; Friedman R; Razin M; Huang W; Krais B; Chorev M; Youdim MB; Weinstock M J Med Chem; 2002 Nov; 45(24):5260-79. PubMed ID: 12431053 [TBL] [Abstract][Full Text] [Related]
11. N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents. Košak U; Knez D; Coquelle N; Brus B; Pišlar A; Nachon F; Brazzolotto X; Kos J; Colletier JP; Gobec S Bioorg Med Chem; 2017 Jan; 25(2):633-645. PubMed ID: 27908752 [TBL] [Abstract][Full Text] [Related]
12. Cyanobiphenyls: Novel H Godyń J; Zaręba P; Łażewska D; Stary D; Reiner-Link D; Frank A; Latacz G; Mogilski S; Kaleta M; Doroz-Płonka A; Lubelska A; Honkisz-Orzechowska E; Olejarz-Maciej A; Handzlik J; Stark H; Kieć-Kononowicz K; Malawska B; Bajda M Bioorg Chem; 2021 Sep; 114():105129. PubMed ID: 34217977 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease. Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289 [TBL] [Abstract][Full Text] [Related]
14. Dual functional cholinesterase and MAO inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of homoisoflavonoid derivatives. Wang Y; Sun Y; Guo Y; Wang Z; Huang L; Li X J Enzyme Inhib Med Chem; 2016; 31(3):389-97. PubMed ID: 25798687 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease. Lan JS; Ding Y; Liu Y; Kang P; Hou JW; Zhang XY; Xie SS; Zhang T Eur J Med Chem; 2017 Oct; 139():48-59. PubMed ID: 28797883 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease. Sang Z; Pan W; Wang K; Ma Q; Yu L; Liu W Bioorg Med Chem; 2017 Jun; 25(12):3006-3017. PubMed ID: 28487125 [TBL] [Abstract][Full Text] [Related]
17. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids. Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease. Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459 [TBL] [Abstract][Full Text] [Related]
19. Chasing ChEs-MAO B Multi-Targeting 4-Aminomethyl-7-Benzyloxy-2 Rullo M; Catto M; Carrieri A; de Candia M; Altomare CD; Pisani L Molecules; 2019 Dec; 24(24):. PubMed ID: 31835376 [TBL] [Abstract][Full Text] [Related]
20. Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors. Pisani L; Iacobazzi RM; Catto M; Rullo M; Farina R; Denora N; Cellamare S; Altomare CD Eur J Med Chem; 2019 Jan; 161():292-309. PubMed ID: 30366255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]